Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID‐19) pandemic: selection criteria and patients’ satisfaction
Open Access
- 21 November 2020
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 192 (2) , E48-E51
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP surveyLeukemia, 2020
- Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemicBritish Journal of Haematology, 2020
- Care of haematology patients in a COVID‐19 epidemicBritish Journal of Haematology, 2020
- Video consultations for covid-19BMJ, 2020
- Telemedicine 2020 and the next decadeThe Lancet, 2020
- Immune ThrombocytopeniaNew England Journal of Medicine, 2019
- Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patientsAmerican Journal of Hematology, 2016
- Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark surveyBMC Cancer, 2016
- Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based StudyJournal of Clinical Oncology, 2015